CAS Search
Related Chemical Product
Buy Chemical NO: 9012-76-4
  • Urgent Purchase CAS NO.:9012-76-4
  • Please post your buying leads! Our suppliers will contact you later!
  • For suppliers to better understand your request, enter more info here.

* Product Name:
CAS No.:
* Quantity:
 
 Metric Ton     Kilogram    Gram    Pound
* Valid For:
 5 Days    15    1 Month    3 Month    6 Month    1 Year
* Description:

Max 2000 characters.  Please enter detailed description for the product.
* Email:
 

Chitosan ( CASNO:9012-76-4 )

Identification and Related Records
Name:
Chitosan
CAS Registry number:
9012-76-4
Synonyms:
Flonac C
Chitosan H
Marinkaito F 05N
Marinkaito F 05S
KW 5
TKS 250N
Sea Cure 123
FCM 117
SK 10 (polysaccharide)
HC 1 (polysaccharide)
North Chitosan MC 1
OTS 2
Sea Cure 143
SK 200
Sea Cure 340
HI-DENSITY CHITOSAN
Chitopearl BCW 3505
Chiton (molluscan common name)Chitopearl 3510
Chitopearl BCW 3507
Hiset KW 5
WOT Recovery Floc T
Kytex M
Sea Cure 243
Chitosan EL
Hydagen HCMF
Profloc 320
EINECS(EC#):
222-311-2
Molecular Formula:
Unspecified
Molecular Weight:
179.17112
Inchi:
InChI=1S/C6H13NO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1,7H2/t2-,3-,4-,5-,6-/m1/s1
InChIKey:
MSWZFWKMSRAUBD-QZABAPFNSA-N
Canonical SMILES:
C(C1C(C(C(C(O1)O)N)O)O)O
Isomers smiles:
C([C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O)N)O)O)O
Chemical and Physical Properties
Appearance:
faintly beige solid
Density:
1.75g/cm3
Melting Point:
88 deg C
Refractive Index:
1.7
Water:
insoluble in water
Solubilities:
insoluble in water
Stability:
Stable. Incompatible with strong oxidizing agents.
Storage temp:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Computed Properties:
Molecular Weight:179.17112 [g/mol]
Molecular Formula:C6H13NO5
XLogP3-AA:-2.8
H-Bond Donor:5
H-Bond Acceptor:6
Rotatable Bond Count:1
Exact Mass:179.079373
MonoIsotopic Mass:179.079373
Topological Polar Surface Area:116
Heavy Atom Count:12
Formal Charge:0
Complexity:155
Isotope Atom Count:0
Defined Atom Stereocenter Count:5
Undefined Atom Stereocenter Count:0
Defined Bond Stereocenter Count:0
Undefined Bond Stereocenter Count:0
Covalently-Bonded Unit Count:1
Feature 3D Acceptor Count:5
Feature 3D Donor Count:5
Feature 3D Cation Count:1
Feature 3D Ring Count:1
Effective Rotor Count:2.2
Conformer Sampling RMSD:0.6
CID Conformer Count:6
Safety and Handling
Hazard Codes:
Xn
Risk Statements:
20/21/22-36/37/38
Safety Statements:
S24/25
Safety:
Hazard Codes:Xn
Risk Statements:20/21/22-36/37/38
20/21/22:Harmful by inhalation, in contact with skin and if swallowed
36/37/38:Irritating to eyes, respiratory system and skin
Safety Statements:24/25-36-26
24/25:Avoid contact with skin and eyes
36:Wear suitable protective clothing
26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice
WGK Germany:-
Formulations/Preparations:
The three forms of glucosamine available commercially are glucosamine hydrochloride, glucosamine sulfate and N-acetyl glucosamine.
Specification:
The Chitosan, with the cas registry number 9012-76-4, is a kind of white colorless solid. This is stable but incompatible with strong oxidizing agents. And its product categories are including Miscellaneous Natural Products; Biochemistry; Polysaccharides; Sugars; Nutritional Supplements; Dextrins Sugar & Carbohydrates. The physical properties of this chemical are as follows: (1)# of Rule of 5 Violations: 3; (2)ACD/BCF (pH 5.5): 1; (3)ACD/BCF (pH 7.4): 1; (4)ACD/KOC (pH 5.5): 1; (5)ACD/KOC (pH 7.4): 1; (6)#H bond acceptors: 48; (7)#H bond donors: 37; (8)#Freely Rotating Bonds: 55; (9)Polar Surface Area: 808; (10)Index of Refraction: 1.701; (11)Molar Refractivity: 336.803 cm3; (12)Molar Volume: 870.564 cm3; (13)Polarizability: 133.519 ×10-24 cm3; (14)Surface Tension: 122.211 dyne/cm; (15)Density: 1.753 g/cm3; (16)Exact Mass: 179.079373; (17)MonoIsotopic Mass: 179.079373; (18)Topological Polar Surface Area: 116; (19)Heavy Atom Count: 12; (20)Complexity: 155. The production method of this chemical is below: Add 20g Chitosan into the 300mL 50% NaOH solvent and wait for its complete infiltration; Then heat to 95℃ for about 1.5 hours, filter out the alkali liquor and then wash to be neutral; Lastly cool and dry to have colorless transparent schistose products 15.6g. As to its usage, it is widely applied in many ways. It could be used as antistaling agent which is usually used in food industry, and thickening agent, flocculating agent; It could also be used in pharmaceutic, agricultural seed, daily expenses, waste water treatment. When you are dealing with this chemical, you should be very cautious. Being a kind of harmful chemicals, it may cause damage to health. If by inhalation, in contact with skin and if swallowed, it is dangerous. Then it is irritating to eyes, respiratory system and skin. Therefore, you shoud take the following instructions. Wear suitable protective clothing, and then avoid contacting with skin and eyes. If in case of contact with eyes, rinse immediately with plenty of water and seek medical advice. In addition, you could convert the following datas into the molecular structure:
(1)Canonical SMILES: C(C1C(C(C(C(O1)O)N)O)O)O
(2)Isomeric SMILES: C([C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O)N)O)O)O
(3)InChI: InChI=1S/C6H13NO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1,7H2/t2-,3-,4-,5-,-/m1/s1
(4)InChIKey: MSWZFWKMSRAUBD-QZABAPFNSA-N?
Octanol/Water Partition Coefficient:
log Kow = -4.2 (est)
Disposal Methods:
SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.
Use and Manufacturing
Use and Manufacturing:
Methods of Manufacturing

Found in chitin, in mucoproteins, and in mucopolysaccharides.
Usage:
Claimed to have the ability to retain fats and cholesterol in the stomach.
Biomedical Effects and Toxicity
Therapeutic Uses:
Glucosamine and chondroitin sulfate are used to treat osteoarthritis. The multicenter, double-blind, placebo- and celecoxib-controlled Glucosamine/chondroitin Arthritis Intervention Trial (GAIT) evaluated their efficacy and safety as a treatment for knee pain from osteoarthritis. 1583 patients with symptomatic knee osteoarthritis /were randomly assigned/ to receive 1500 mg of glucosamine daily, 1200 mg of chondroitin sulfate daily, both glucosamine and chondroitin sulfate, 200 mg of celecoxib daily, or placebo for 24 weeks. Up to 4000 mg of acetaminophen daily was allowed as rescue analgesia. Assignment was stratified according to the severity of knee pain (mild [N=1229] vs. moderate to severe [N=354]). The primary outcome measure was a 20 percent decrease in knee pain from baseline to week 24. The mean age of the patients was 59 years, and 64 percent were women. Overall, glucosamine and chondroitin sulfate were not significantly better than placebo in reducing knee pain by 20 percent. As compared with the rate of response to placebo (60.1 percent), the rate of response to glucosamine was 3.9 percentage points higher (P=0.30), the rate of response to chondroitin sulfate was 5.3 percentage points higher (P=0.17), and the rate of response to combined treatment was 6.5 percentage points higher (P=0.09). The rate of response in the celecoxib control group was 10.0 percentage points higher than that in the placebo control group (P=0.008). For patients with moderate-to-severe pain at baseline, the rate of response was significantly higher with combined therapy than with placebo (79.2 percent vs. 54.3 percent, P=0.002). Adverse events were mild, infrequent, and evenly distributed among the groups. Glucosamine and chondroitin sulfate alone or in combination did not reduce pain effectively in the overall group of patients with osteoarthritis of the knee. Exploratory analyses suggest that the combination of glucosamine and chondroitin sulfate may be effective in the subgroup of patients with moderate-to-severe knee pain. [Clegg DO et al; New Eng J Med 354: 795-808 (2006)]
Biomedical Effects and Toxicity:
Information on the absorption and serum pharmacokinetics for dietary glucosamine is very limited, and in some case, the available data are contradictory. For example, in one series of studies, (14)C-glucosamine was given orally to rats, dogs, and humans, and in all cases, the radiolabel was described as "efficiently" absorbed, reaching a plasma peak after about 4 hours. A high percentage of the radiolabel (about 35%) was excreted in the urine, and a similar amount was last in expired air. On the other hand, the laboratory that conducted this experiment was unable to detect chemical amounts of glucosamine in human serum after a single oral dose at 100 mg/kg (five times the clinical dose) using a chromatographic assay with a limit of detection of about 14 uM. This suggests that the bioavailable glucosamine in human serum after the normal recommended dosage (20 mg/kg) is well below 10 uM.
About 90% of glucosamine administered orally as a glucosamine salt get absorbed from the small intestine, and from there it is transported via the portal circulation to the liver. It appears that a significant fraction of the ingested glucosamine is catabolized by first-pass metabolism in the liver. Free glucosamine is not detected in the serum after oral intake, and it si not presently known how much of an ingested dose is taken up in the joints in humans. Some uptake in the articular cartilage is seen in animal studies.
Twelve healthy volunteers received three consecutive once-daily oral administrations of glucosamine sulfate soluble powder at the doses of 750, 1,500, and 3,000 mg, in an open, randomised, cross-over fashion. Glucosamine was determined in plasma collected up to 48 hr after the last dose. ... Endogenous plasma levels of glucosamine were detected (10.4-204 ng/ml, with low intra-subject variability). Glucosamine was rapidly absorbed after oral administration and its pharmacokinetics were linear in the dose range 750-1,500 mg, but not at 3,000 mg, where the plasma concentration-time profiles were less than expected based on dose-proportionality. Plasma levels increased over 30-folds from baseline and peaked at about 10 microM with the standard 1,500 mg once-daily dosage. Glucosamine distributed to extravascular compartments and its plasma concentrations were still above baseline up to the last collection time. [Persiani S et al; Osteoarthritis Cartilage 13 (12): 1041-9 (2005)] PubMed Abstract
Eighteen subjects with osteoarthritis were given 1,500 mg of commercial glucosamine sulphate after an overnight fast, and serum was then obtained at baseline and every 15-30 minutes over 3 hours, and additionally, from two subjects at 5 and 8 hours. Urine samples were collected at baseline and 3 hours after ingestion from three subjects. Baseline glucosamine was below the detection limit of 0.5 umol/L for all subjects, but after ingestion, glucosamine was detected in 17/18 subjects, beginning to rise at 30-45 minutes to a maximum at 90-180 minutes, with a range of 1.9-11.5 umol/L (0.34-2 ug/ml). [Bittee BA et al; Ann Rheum Dis 65 (2): 222-6 (2006)] PubMed Abstract
The purpose of this study was to determine if glucosamine (GL) hydrochloride (FCHG49) and low molecular weight (LMW) chondroitin sulfate (CS) (TRH122) are absorbed after oral administration to horses. The bioavailability of LMWCS was evaluated by quantifying the total disaccharides found in the plasma following chondroitinase ABC digestion. Two separate studies were conducted. In study 1, ten adult horses received the following four treatments in a randomized crossover fashion: (1) i.v. LMWCS (3 g of 8 kDa), (2) p.o. LMWCS (3 g of 8 kDa), (3) i.v. LMWCS (3 g of 16.9 kDa) and (4) p.o. LMWCS (3 g of 16.9 kDa). Each group received 9 g GL with LMWCS. In a second study, each horse (n=2) was randomly assigned to receive either i.v. administration of GL HCl (9 g) or p.o. administration of GL HCl (125 mg/kg). Blood samples were collected, assayed and pharmacokinetic parameters were determined. GL was absorbed after oral dosing with a mean C(max) of 10.6 (6.9) ug/ml and a mean T(max) of 2.0 (0.7) hr. The extent of absorption of LMWCS after dosing with both the 8.0 and 16.9 kDa provides evidence that LMWCS is absorbed orally. C(max) and AUC were higher (pPubMed Abstract
The purpose of this study was to determine the oral bioavailability and pharmacokinetics of a glucosamine and the disaccharides of chondroitin sulfate after single and multiple-dosing of a glucosamine/chondroitin sulfate combination (Cosamin, Cosequin). Male beagle dogs (n = 8, 12 kg) received the following treatments: (1) IV glucosamine (500 mg)/chondroitin sulfate (400 mg), (2) p.o. glucosamine (1500 mg)/chondroitin sulfate (1200 mg), (3) p.o. glucosamine (2000 mg)/chondroitin sulfate (1600 mg), (4) p.o. glucosamine (1500 mg)/chondroitin sulfate (1200 mg) QD for days 1-7 and p.o. glucosamine (3000 mg)/chondroitin sulfate (2400 mg) from days 8 to 14. Blood samples were collected over 24 hr and glucosamine and the disaccharides of chondroitin sulfate were determined. Pharmacokinetic analysis was performed on glucosamine and total chondroitin sulfate disaccharides and parameters were compared across treatments using ANOVA with post hoc analysis. After the IV administration, glucosamine declined rapidly in a bi-exponential fashion with a mean (+ or - S.D.) elimination t(1/2) of 0.52 (0.25) hr. Glucosamine absorption was relatively fast (C(max) = 8.95 ug/ml, and T(max) 1.5 h after 1500 mg dose) and the mean bioavailability of glucosamine after single dosing was approximately 12%. The extent of absorption of chondroitin sulfate as indicated by the mean C(max) (21.5 ug/ml) and mean AUC (187 ug/ml hr) of total disaccharides after dosing (1600 mg) provides evidence that chondroitin sulfate is absorbed orally. The bioavailability of chondroitin sulfate ranged from 4.8 to 5.0% after single dosing and 200-278% upon multiple dosing. The results of this study show that both glucosamine and chondroitin sulfate (measured as total disaccharides) are bioavailable after oral dosing. In addition, the low molecular weight chondroitin sulfate used in this study displays significant accumulation upon multiple dosing. [Adebowale A et al; Biopharm Drug Dispos 23 (6): 217-25 (2002)] PubMed Abstract
The pharmacokinetics of glucosamine sulfate was investigated in 6 healthy male volunteers (2 per administration route) using (14)C uniformly labelled glucosamine sulfate and administering it in single dose by intravenous (i.v.), intramuscular (i.m.) or oral route. The results show that after i.v. administration the radioactivity due to glucosamine appears in plasma and is rapidly eliminated, with an initial t1/2 of 0.28 hr. 1-2 hr after administration the radioactivity due to glucosamine disappears almost completely and is replaced by a radioactivity originating from plasma proteins, in which glucosamine or its metabolites are incorporated. This radioactivity reaches a peak after 8-10 hr and then declines with a t1/2 of 70 hr. About 28% of the administered radioactivity is recovered in the urine of the 120 hr following the administration and less than 1% is recovered in the feces. After i.m. administration similar pharmacokinetic patterns are observed. After oral administration a proportion close to 90% of glucosamine sulfate is absorbed. Free glucosamine is not detectable in plasma. The radioactivity incorporated in the plasma proteins follows pharmacokinetic patterns which are similar to those after i.v. or i.m. administration, but its concentration in plasma is about 5 times smaller than that after parenteral administration. The AUC after oral administration is 26% of that after i.v., or i.m. administration. The smaller plasma levels of radioactivity after oral administration are probably due to a first pass effect in the liver which metabolizes a notable proportion of glucosamine into smaller molecules and ultimately to CO2, water and urea. [Setnikar I et al; Arzneimittelforschung 43 (10): 1109-13 (1993)] PubMed Abstract
Environmental Fate and Exposure Potential
Environmental Fate/Exposure Summary:
TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 10(SRC), determined from a structure estimation method(2), indicates that glucosamine is expected to have very high mobility in soil(SRC). The pKa of glucosamine is 7.58(3), indicating that this compound will partially exist in cation form in the environment and cations generally absorb more strongly to soils containing organic carbon and clay than their neutral counterparts(4). Volatilization of the neutral form of glucosamine from moist soil surfaces is not expected to be an important fate process(SRC) given an estimated Henry's Law constant of 7.7X10-16 atm-cu m/mole(SRC), using a fragment constant estimation method(5). Volatilization of the cation from moist soil surfaces will not occur as ionic species do not volatilize. Glucosamine is not expected to volatilize from dry soil surfaces(SRC) based upon an estimated vapor pressure of 9.0X10-8 mm Hg(SRC), determined from a fragment constant method(6). Glucosamine is expected to biodegrade fairly rapidly in aerobic soil environments based on a grab sample study using two different soils where 36 and 56% mineralization and 65 and 70% mineralization were reported after 1 and 8 weeks, respectively(7).
AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 10(SRC), determined from a structure estimation method(2), indicates that glucosamine is not expected to adsorb to suspended solids and sediment(SRC). However, glucosamine will exist partially in the cation form at pH values of 5 to 9 based on a pKa of 7.58(5) and cations generally adsorb more strongly to organic carbon and clay than their neutral counterparts(6). Volatilization from water surfaces is not expected(3) for the neutral species based upon an estimated Henry's Law constant of 7.7X10-16 atm-cu m/mole(SRC), developed using a fragment constant estimation method(4). Volatilization of the cation from water surfaces is not expected to occur as ionic species do not volatilize. According to a classification scheme(7), an estimated BCF of 3(SRC), from an estimated log Kow of -4.2(8) and a regression-derived equation(9), suggests the potential for bioconcentration in aquatic organisms is low(SRC). Glucosamine is expected to biodegrade fairly rapidly in aerobic water based on a soil grab sample study using two different soils where 36 and 56% mineralization and 65 and 70% mineralization were reported after 1 and 8 weeks, respectively(10).
ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), glucosamine, which has an estimated vapor pressure of 9.0X10-8 mm Hg at 25 deg C(SRC), determined from a fragment constant method(2), is expected to exist solely in the particulate phase in the ambient atmosphere. Particulate-phase glucosamine may be removed from the air by wet or dry deposition(SRC). Glucosamine does not contain a chromophore that absorbs at wavelengths >290 nm and therefore is not expected to be susceptible to direct photolysis by sunlight(3).
Chemical Company
Qi Long Electronic Co.,Ltd:
QiLong Electronic Co.,Ltd is a manufacturer which undertakes the research,Website:http://www.qilonglotto.com,production and sales of lottery machine in China. Our company has many years experience in producing lotto products, including lottery machine, bingo machine, lotto draw machine,top lotto machine , casino machine, event equipment, keno draw machine, top table bingo machine, prize wheel, lucky wheel,bingo ball, keno ball, lotto ball and RFID ball etc. We can also design for you according to your requirement. 
Kunshan Razer Pesticides Co.,Ltd.:
 
Wu Xi Chuang Hui Metal Product Co Ltd:
Wu Xi Chuang Hui Metal Product Co.,Ltd is a professional echnology-based enterprises which aims to produce and sell the precision cold-rolled flat steel bright and cold-drawn steel. Products are mainly used for door and window hardware,Website:http://www.cnchjs.com, precision metal manufacturing, stamping standard, logistics equipment, medical equipment, machinery manufacturing, technology products, stent products, hardware and tools, appliances, decoration, auto parts, logistics and other major industries. Our company follows high-quality technology development strategy and the integrity of the attitude of service since its inception. From product development, production and sales and after-sales service, all the processes are strictly in accordance with the requirements of industry qual 
Airsea(Taizhou) Pharmaceutical Co., Ltd.:
 
Shanghai Zhuohe Internationl Co., Ltd.:
profile: Shanghai Zhuohe Worldwide Co., Ltd. is involved in import & export of items coping with chemical, Plastic, mechanical, Auto parts and new energy materials. Our chemical items are guanidine sulfamate, Dicyanodiamide, thiocarboxylic chemicals and acryl monomers. We supply active pharmaceutical components and finished items. 
Anyang Dawei Metallurgical Refractories Co.,Ltd:
Anyang Dawei Metallurgical Refractories Co.,Ltd,Website:http://www.dwmetallurgical.com,specializing in manufacturing and sales of metallurgy materials, is located in Development Zone,Longquan Town,Anyang city,north of Henan province,where is the junction of Sanxi, Hebei and Henan provinces, so it is very convenient in transportation. In culture,Anyang is Chinese character capital and the locality of inscriptions on bones or tortoise shells, Anyang is also the cradle of Zhouyi and one of Chinese famous old capital the eight dynasties. In economy, Anyang city is Chinese collecting and distributing centre of the ferroalloy. In a way, we can say, Anyang has been making great contributions to Chinese steel industry. Anyang Dawei Metallurgical Refractories Co.,Ltd,was a little refractory firm at 
Landmark Nutraceuticals Co.:
 
Jinan Runtai Ex&Im Co. Ltd:
Jinan Runtai Ex&Im Co.,Ltd started in March 2005. Its predecessor was GaoTangXian cast sincere burden Co.Ltd. Some steel-making furnaces materials production and processing, distribution, chemical, ammonium sulfite, bisulfite ammonium production, steelTrade and Industry Branch U . s . Co.Ltd.The key method is use to increasecarbon steel casting agent, industrial utilisation of the ammonium sulfate, medicine with ammonium hydrogen sulfite.Our organization covers a place of 300 acres,the development plant is situated in Liaocheng Gaotang.The registered capital of 35.4 million yuan, existing staff greater than 300 people, has five production workshop, high-tech professional talents using more than 30 people, top quality staff.The organization not just has high-quality marketing personnel,  
Shenzhen Kedida Electronics Co.,Ltd:
Henzhen Kedida Electronics Co.,Ltd is really a colligated high-tech enterprise integrating re search and development, manufacturing, Marketing and engineering services of indust rial automation items. The organization includes five In line with the principle of we feedback to clients with better and better items, and more and more sincere s ervices. The organization consider because the principal for entrepreneurship and development. Yo ur concern and trust would be the source to advertise our progress. We will give you quality items and services to come back your ex and Support.//http://world wide web.phkedida.com  
Timothy Holding Co.,Ltd.:
Imothy Holding Co., Ltd.began in 1993. It has been specialized in producing universal joint shafts (also known as cardan shaft or drive shaft) In excess of two decades. Our items are largely utilized in moving mills,Pipe Hair straighteners,steel mill,tube mill,Continuous casting machinery,Paper machines ,Piercing mills,bridge cranes,steckel mill,punchers,Curler conveyor, Rotating Furnace,mining machinery and other heavy duty machinery .After enormous efforts for several years, it's easily passed ISO9001 quality system certification, and plus it has built lengthy-term cooperation relationship with lots of domestic and oversea crane and steel industrial facilities. Our items happen to be broadly utilized in Baosteel Group Corporation,Dalian Huarui Heavy Industry Co.,Ltd.(DHHI), Taiyuan Heav 
Ji'nan Orgachem Pharmaceutical Co.,Ltd:
Ji'nan Orgachem Pharmaceutical Co.,Ltd is really a professional manufacturer in chemical and pharmaceutical materials, is an expert within the research, production, purchase and technology service of chemicals, pharmaceutical recycleables and Intermediates. We are strong at technology, and has possess a research institute which has the efficiency on research. 
Yangzhou Wealth Traveling Articles CO.,LTD:
Yangzhou Wealth Traveling Articles Co., Ltd was established in 2007,Website:http://www.wealthslipper.net, which is a company combines manufacturing with trade. The main products include hotel slippers, eye masks, earplugs, inflatable pillows and travel kits. We are a large manufacturer with the lines of development, production, trade and service, which provide more than three hundred star hotels with high quality hotel consumables and aviation supplies home and abroad. Our cooperative high-end clients include Marriott, United Airlines, Four Seasons Hotels and so on. 
S.P.TmpexPVT.Ltd.:
 
Danyang Weilong Tools Co.,Ltd:
Weilong Tools Co., Ltd. is a specialized manufacturer of carbide alloy cutting discs. With advanced technique and equipment procured from home and abroad,Website:http://www.weilong-tools.com.cn, as well as strong technical know-how expertise, assisted by the first-class production center, first-class heat treatment center and first-class testing center, under strict quality control, we make high quality cutting discs of quality alloy material. Our major products: Carbide alloy carpentry discs, grass cutting discs, iron cutting discs, aluminium cutting discs, and the cutting discs matching for electrical tools, etc,. in almost 200 specifications. The products are sold to marketplace in countries and regions of Japan, USA, Australia and so on, enjoying wide popularity among the customers.  
Tianjin Zhongtetesi Import and Export Co.,Ltd:
Ianjin Zhongtetesi Import and Export Co., LTD is really a private joint-stock corporation,integrating manufacture and purchase of chemical items.we've independent import and export privileges,solely supplying top quality Polyvinyl Alcohol, titanium dioxide, lithopone, Zinc, glacial acetic acidity, Iron Oxide, Calcium Chloride Hexahydrate, Poly aluminium chloride, Aluminium Sulfate, Sodium sulfite, carbon black, chrome oxide eco-friendly, and various other items.Our items not just sell well locally, but in addition have a large market in overseas marketplaces, for example Japan, Korea, the U . s . States, Europe and Southeast Asia. with independent import and export privileges, we've stocks in Lianyungang Port, Shanghai Port, Zhenjiang Port, Nantong Port and Tianjin New Port to meet the req 
Shanghai Fuda Fine Chemicals Co., Ltd.:
Shanghai Fuda Fine Chemicals Co., Ltd. began in 1995,that is a joint-venture invested through the School of Chemistry & Chemical Technology of Shanghai Jiao Tong College and Shanghai Songlin Industrial & Commercial Co., Ltd. Shanghai Fuerfu Niche material Technology Development Co., Ltd. may be the production base of Shanghai Fuda Fine Chemicals Co., Ltd.Primary Items in our Company: 1, 2, 4-Butanetriol Feed Additive Ethoxyquin Mould Inhibitor Mei Ke Xin Xing Rubber Antioxidant BLE & AW. 
Nanjing Jinyan Strontium Chemical Co., Ltd:
 
Topharman Shanghai Co .,Ltd .:
 Like a leading innovation-driven contract research and manufacturing organization for pharmaceutical, Biotechnology, and chemical industries with operation in China and U . s . States,Topharman continues to be dedicated to expedite our customer's R&D and manufacturing currently- and cost-effective manner since 2000 at any phase: Discovery, lead optimisation, process development, and commercial manufacture. Our R&D Center, Situated in Shanghai, China and outfitted using the condition-of-the-art instruments, employees over 90 chemists and researchers. Our experienced scientific employees are dedicated to supplying our clients with reliable quality and competitive cost through innovation. 
MHC-pcn Industrial CO.,LTD:
MHC INDUSTRIAL CO., LTD is really a high-tech enterprise which complements in technology and management. The company is a manufacturer of raw materials for global healthy industry . It is an expert in supplying stable quality, safe and reliable active substance for pharmaceutical. Located in "honesty, Innovation first, practical-based" business philosophy, the effective and practical management tarm of MHC supplies a offered fundamentals for developing and further propeling "MHC" to become a brand of the profession leader. The organization gathers impeccable extraction, isolation, purification, synthesis fermentation equipment and Tech, familiar with production &lifier strict qc system, established consummation purchase system. the items are released to Europe, americ 
Beijing Beiqing Chuangye Sci. & Tech. Development Co., Ltd.:
profile: Beijing Beiqing Chuangye Sci. & Tech. Development Co., Ltd. is an expert in producing new medicine, DRUG MATERIALS, fine chemical items and Plant Extracts. Our items are fluorene, p-tolualdehyde, Vinblastine Sulfate, 2-amino-3,5-dinitrothiophene, Vincristine sulfate, vindoline, catharanthine, 3,4-dimethylbenzaldehyde, N-hydroxy-5-norbornene-2,3-dicarboximide, 9-fluorenemethanol, 1-hydroxy-7-azabenzotriazole, benzotriazol-1-yloxytris(dimethylamino)-phosphonium hexafluorophosphate,2-(1h-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate and 2-(7-aza-1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate.